Grants are slow. VCs are crowded. Frontier biology stalls in the gap. vrials turns your research into a liquid asset on day one, funded by believers, not delayed by committees.
Bonding curve, public price, instant cap table, without the legal and technical scaffolding biotech actually needs. Real market signal before you burn a year of runway.
Holders become your distribution. Community becomes your beta. The molecule with the most conviction wins and vrials puts you in front of them at lightning speed.
On-chain traction becomes your strongest TAM proof. We connect you to what follows: patent counsel, downstream VCs, CROs, and operators. The market validates the science and we connect you to the institutional path.